Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Duke Clinical: A Phase 2, Randomized, Double-blind, Placebo-controlled, Proof-of-concept Trial for OPC-131461 in Patients who Have Been Hospitalized for Worsening Heart Failure and Have Laboratory Evidence of Incomplete Decongestion Follow
Skopicki, H. (PI), Goldschmidt, M. (CoPI), Jang, K. (CoPI) & Tam, E. (CoPI)
Otsuka Pharmaceutical Development and Commercialization Inc
06/25/25 → 06/24/26
Project: Research
-
ALgorithm using LINQ Sensors for EValuation And TreatmEnt of Heart Failure (ALLEVIATE-HF)
Skopicki, H. (PI), Almasry, I. (CoPI), Chen, O. (CoPI), Goldschmidt, M. (CoPI), Jang, K. (CoPI), Rashba, E. (CoPI) & Tam, E. (CoPI)
09/2/23 → 06/17/26
Project: Research
-
Impella-Supported PCI in High-Risk Patients with Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial
Lawson, W. (PI), Goldschmidt, M. (CoPI), Heslin, R. (CoPI), Jang, K. (CoPI), Parikh, P. (CoPI), Skopicki, H. (CoPI), Tam, E. (CoPI), Pyo, R. (PI) & Weinstein, J. (CoPI)
12/3/21 → 02/10/27
Project: Research
-
REDEFINE-HF: A Randomized, Double-Blind, Placebo-Controlled Pragmatic Study to Evaluate the Efficacy and Safety of Finerenone in Patients with Heart Failure and Reduced Ejection Fraction who are Intolerant of or not Suitable for...
Skopicki, H. (PI), Goldschmidt, M. (CoPI), Jang, K. (CoPI), Riquelme, L. (CoPI), Tam, E. (CoPI), Borriello, C. (CoPI), Pilato, L. (CoPI) & Reilly, P. (CoPI)
01/29/25 → 08/13/25
Project: Research
-
A Phase 3 Randomized Double-Blind Placebo-Controlled Event-Driven Study to Investigate the Effect of Retatrutide on the Reduction of Major Adverse Cardiovascular Events (MACE) and/or Adverse Kidney Outcomes in Participants with Body Mass...
Skopicki, H. (PI), Goldschmidt, M. (CoPI), Jang, K. (CoPI), Riquelme, L. (CoPI), Tam, E. (CoPI), Borriello, C. (CoPI), Pilato, L. (CoPI) & Reilly, P. (CoPI)
10/21/24 → 03/8/26
Project: Research
-
Colorectal cancer in heart transplant recipients: A competing risk analysis
Abboud, A., Tajerian, A., Charles, S., Clores, M., Goldschmidt, M., Aroniadis, O. & Kalogeropoulos, A., Jan 2026, In: European Journal of Clinical Investigation. 56, 1, e70107.Research output: Contribution to journal › Article › peer-review
-
Ischemic cardiomyopathy: epidemiology, pathophysiology, outcomes, and therapeutic options
Pastena, P., Frye, J. T., Ho, C., Goldschmidt, M. E. & Kalogeropoulos, A. P., Jan 2024, In: Heart Failure Reviews. 29, 1, p. 287-299 13 p.Research output: Contribution to journal › Review article › peer-review
64 Scopus citations -
Point of Care Ultrasound (POCUS) in the Management of Heart Failure: A Narrative Review
Naddaf, N., Dianati Maleki, N., Goldschmidt, M. E. & Kalogeropoulos, A. P., Jul 2024, In: Journal of Personalized Medicine. 14, 7, 766.Research output: Contribution to journal › Review article › peer-review
Open Access11 Scopus citations -
Sacubitril/Valsartan and Cognitive Outcomes in Heart Failure With Reduced Ejection Fraction
Grewal, P. K., Abboud, A., Myserlis, E. P., Goldschmidt, M. E., Butler, J., Skopicki, H. A. & Kalogeropoulos, A. P., Jun 2023, In: JACC: Advances. 2, 4, 100372.Research output: Contribution to journal › Article › peer-review
Open Access18 Scopus citations -
Safety of Outpatient Milrinone Infusion in End-Stage Heart Failure: ICD-Level Data on Atrial Fibrillation and Ventricular Tachyarrhythmias
Harhash, A. A., Cassuto, J., Hussein, A., Achu, E., Zucker, M. J., Goldschmidt, M., Alpert, J. S. & Baran, D. A., Jul 2020, In: American Journal of Medicine. 133, 7, p. 857-864 8 p.Research output: Contribution to journal › Article › peer-review
9 Scopus citations